{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:15:54Z","timestamp":1791875754977,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.metabol.2022.155220","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:33:15Z","timestamp":1653269595000},"page":"155220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study"],"prefix":"10.1016","volume":"133","author":[{"given":"Hexiang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enci","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for nafld: a consensus statement","volume":"19","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155220_bb0015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2022.155220_bb0020","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155220_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/dom.14597","article-title":"Young adults with nonalcoholic fatty liver disease defined using fatty liver index can be at increased risk for myocardial infarction or stroke","volume":"24","author":"Chung","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.metabol.2022.155220_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/rssa.12343","article-title":"Mendelian randomization: methods for using genetic variants in causal estimation","volume":"181","author":"Little","year":"2018","journal-title":"J R Stat Soc A Stat"},{"issue":"7","key":"10.1016\/j.metabol.2022.155220_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155220_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-7868-7_13","article-title":"A primer in mendelian randomization methodology with a focus on utilizing published summary association data","volume":"1793","author":"Dimou","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"13","key":"10.1016\/j.metabol.2022.155220_bb0050","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"issue":"9501","key":"10.1016\/j.metabol.2022.155220_bb0055","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","article-title":"Nature's randomised trials","volume":"366","author":"Hingorani","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2022.155220_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million veteran program: a mega-biobank to study genetic influences on health and disease","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.metabol.2022.155220_bb0065","unstructured":"M Vujkovic S Ramdas KM Lorenz , et al. A trans-ancestry genome-wide association study of unexplained chronic alt elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. medRxiv. 20212020.12.26.20248491. doi:10.1101\/2020.12.26.20248 491."},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/CS20070080","article-title":"Arterial stiffness: clinical relevance, measurement and treatment","volume":"113","author":"Hamilton","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"13","key":"10.1016\/j.metabol.2022.155220_bb0075","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0080","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1038\/s41598-019-45703-0","article-title":"Genome-wide association study identifies loci for arterial stiffness index in 127,121 Uk biobank participants","volume":"9","author":"Fung","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.metabol.2022.155220_bb0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.metabol.2022.155220_bb0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155220_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155220_bb0115","series-title":"Statistical Inference in Two-sample Summary-data Mendelian Randomization Using Robust Adjusted Profile Score","author":"Zhao","year":"2018"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155220_bb0125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155220_bb0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing mendelian randomization investigations","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res."},{"issue":"2","key":"10.1016\/j.metabol.2022.155220_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between nafld, t2d and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.metabol.2022.155220_bb0140","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.metabol.2022.155220_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.01.045","article-title":"Mendelian randomization analysis reveals no causal relationship between nonalcoholic fatty liver disease and severe covid-19","author":"Li","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155220_bb0150","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155220_bb0155","first-page":"379","article-title":"Arterial compliance (stiffness) as a marker of subclinical atherosclerosis","volume":"32","author":"Nurnberger","year":"2007","journal-title":"Herz"},{"issue":"8","key":"10.1016\/j.metabol.2022.155220_bb0160","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/01.hjh.0000239277.05068.87","article-title":"Contour analysis of the photoplethysmographic pulse measured at the finger","volume":"24","author":"Millasseau","year":"2006","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.metabol.2022.155220_bb0170","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/HJH.0b013e32833a7de6","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: the cardio-goose study","volume":"28","author":"Salvi","year":"2010","journal-title":"J Hypertens"},{"issue":"Pt 20","key":"10.1016\/j.metabol.2022.155220_bb0175","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1113\/jphysiol.2010.194753","article-title":"Arterial stiffening with ageing is associated with transforming growth factor-beta1-related changes in adventitial collagen: reversal by aerobic exercise","volume":"588","author":"Fleenor","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.metabol.2022.155220_bb0180","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2741\/gressner","article-title":"Roles of tgf-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"issue":"22","key":"10.1016\/j.metabol.2022.155220_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.metabol.2022.155220_bb0190","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0195","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","article-title":"Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease","volume":"58","author":"Hallsworth","year":"2013","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.metabol.2022.155220_bb0200","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: jacc state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155220_bb0205","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155220_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.680664","article-title":"The risk of type 2 diabetes and coronary artery disease in non-obese patients with non-alcoholic fatty liver disease: a cohort study","volume":"8","author":"Dai","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.metabol.2022.155220_bb0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155220_bb0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.metabol.2022.155220_bb0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0230","article-title":"Identification of 90 nafld gwas loci and establishment of nafld prs and causal role of nafld in coronary artery disease","volume":"3","author":"Miao","year":"2022","journal-title":"HGG Adv"},{"issue":"12","key":"10.1016\/j.metabol.2022.155220_bb0235","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in pnpla3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155220_bb0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.01.029","article-title":"Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps","volume":"282","author":"Santos","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155220_bb0245","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2021.0406","article-title":"Nafld increases risk of carotid atherosclerosis and ischemic stroke. An updated meta-analysis with 135,602 individuals","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"R2","key":"10.1016\/j.metabol.2022.155220_bb0250","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1093\/hmg\/ddr345","article-title":"Stroke genetics","volume":"20","author":"Markus","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.metabol.2022.155220_bb0255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.gene.2014.11.015","article-title":"Genetic determinants in ischaemic stroke subtypes: seven year findings and a review","volume":"555","author":"Munshi","year":"2015","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.metabol.2022.155220_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOL.0000000000000799","article-title":"Fatty liver and cerebrovascular disease: plausible association and possible mechanisms","volume":"33","author":"Khanna","year":"2021","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155220_bb0265","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/ene.15277","article-title":"Non-alcoholic fatty liver disease and stroke: a mendelian randomization study","volume":"29","author":"Wu","year":"2022","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155220_bb0270","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","article-title":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?","volume":"33","author":"Bhatia","year":"2012","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.metabol.2022.155220_bb0275","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155220_bb0280","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.metabol.2022.155220_bb0285","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.metabol.2022.155220_bb0290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00125-019-05024-3","article-title":"Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality","volume":"63","author":"Brouwers","year":"2020","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.metabol.2022.155220_bb0295","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.metabol.2022.155220_bb0300","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:29:59Z","timestamp":1758428999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":59,"alternative-id":["S0026049522000981"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155220","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155220"}}